Tina Marie Devries

EVP, Research & Development, RVL Pharmaceuticals plc.

Companies

RVL Pharmaceuticals plcEVP, Research & Development Oct 18, 2018 to May 20, 2022¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

RVL Pharmaceuticals plc136,141 shares²May 18, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

May 18, 2022Shares withheld for tax 5,447 shares at $1.40 of RVL Pharmaceuticals plc²
Jan 24, 2022Shares withheld for tax 9,607 shares at $1.13 of RVL Pharmaceuticals plc³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARRVL Pharmaceuticals plc, EVP, Research & Development
2
SEC EDGARRVL Pharmaceuticals plc shares after the filing of May 18, 2022
3
SEC EDGARForm 4 filed Jan 26, 2022